Wilandt Brothers S.A.
Activities of head office and holding companies, excluding financial holding companies
Overview
Wilandt Brothers is a dynamically developing company in the Health Technology sector that focuses on delivering effective and rigorously tested products and solutions aimed at improving health and lives worldwide. The company emphasizes the importance of balancing people, technology, and business to achieve optimal results in healthcare.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $0 | |
| Profit allocation | Retained in reserve capital | |
| Receivables write-downs | $914,114 | |
| Management board pay | $45,203 | |
| Deferred tax assets | $175,639 | |
| Merger or transformation | Yes |
Filing timeliness
Financial statements were filed on time, on average 7 days early. All were audited by a statutory auditor.
- 202514/07/2026
- 202411/07/2025
- 202312/07/2024
- 202226/06/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Websites
- wilandt.comWilandtSAGoogle AnalyticsGoogle Tag ManagerLLiteSpeed
Job offers
The company lists 1 job opening on its own careers page: wilandt.com/career.
Authorized Representatives
Manner of representation
In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Wilandt Brothers Pl sp. z o.o. | 1,377.63 USD | 100% | ||
Bowil Biotech sp. z o.o. | 648,298.22 USD | 100% |
Bank accounts
Registered as a VAT taxpayer on 2021-07-21.
21 1020 1068 0000 1302 0526 6939
92 1240 1239 1111 0011 0724 2861
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Biovico sp. z o.o. | $32,716,605.20 | biovico.com | ||
| Synkmed sp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| Synektik Pharma sp. z o.o. | $13,215,198.91 | synektik.com.pl | ||
| Paso-Trading sp. z o.o. | $12,314,433.40 | paso-trading.pl | ||
| Zakład Techniki Medycznej Tech-Med sp. z o.o. | $7,640,728.17 | technikawmedycynie.pl | ||
| MBM Pharma sp. z o.o. | $6,126,944.60 | mbmpharma.pl | ||
| Carbomech sp. z o.o. | $5,518,006.66 | carbomech.com.pl | ||
| Paper&Nonwoven Mem Group sp. z o.o. + limited partnership | $4,358,114.88 | panw.pl | ||
| Meditrade Poland sp. z o.o. | $1,940,256.95 | meditrade.com.pl | ||
| Metzer Medizin- Und Industrietechnik sp. z o.o. | $1,511,723.18 | metzer.pl |
Change history
| Date | Event | |
|---|---|---|
| 2021-12-21 | Share capital increase (120,000.00 PLN → 28,936,797.00 PLN) | |
| 2021-07-21 | Entered in the register |
FAQ
Last updated: 2026-09-02